Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review.

Immunosequencing has emerged as a newer clinical test for assessment of T cell clonality in the blood and skin of cutaneous T-cell lymphoma (CTCL)...

Primary anaplastic-lymphoma-kinase (ALK)-positive large-cell lymphoma of the central nervous system (PCNS ALK-positive ALCL) is a rare entity, with a...

Multiple myeloma is the second most common malignant hematologic malignancy which evolved different strategies for immune escape from the host immune...

Linear IgA bullous dermatosis in association with nodal peripheral T cell lymphoma with a T follicular helper phenotype and multiple myeloma: a case...

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a distinct subtype of T-cell non-Hodgkin lymphoma that arises in the context of...

Severe and continuous immunoparesis during induction or maintenance therapy in nontransplant patients with multiple myeloma is a sign of poor...

Research progress of the chemokine/chemokine receptor axes in the oncobiology of multiple myeloma (MM).

Due to the rarity of angioimmunoblastic T-cell lymphoma (AITL), very limited data concerning its incidence patterns and prognostic factors are...

This study confirms the hypothesis of lymphatic dissemination of HL in a contiguous mode, with additional links between more distant regions

The findings reported by Junjie Huang and colleagues, published in The Lancet Haematology, elaborate on the recent trends in the epidemiology of...

We aimed to examine the worldwide incidence, mortality, associated risk factors, and temporal trends of multiple myeloma by sex, age, and geographical...